These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15356338)

  • 1. Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30).
    Burgess SC; Young JR; Baaten BJ; Hunt L; Ross LN; Parcells MS; Kumar PM; Tregaskes CA; Lee LF; Davison TF
    Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13879-84. PubMed ID: 15356338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo.
    Kumar S; Kunec D; Buza JJ; Chiang HI; Zhou H; Subramaniam S; Pendarvis K; Cheng HH; Burgess SC
    BMC Syst Biol; 2012 Sep; 6():123. PubMed ID: 22979947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the proteome of a Marek's disease transformed cell line: a natural animal model for CD30 overexpressing lymphomas.
    Buza JJ; Burgess SC
    Proteomics; 2007 Apr; 7(8):1316-26. PubMed ID: 17443643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal expression and DNA hypomethylation profile of CD30 in Marek's disease virus-infected chicken spleens.
    Li K; Lian L; Yang N; Qu L
    Poult Sci; 2015 Jun; 94(6):1165-9. PubMed ID: 25840961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling in rMd5- and rMd5deltameq-infected chickens.
    Xu M; Zhang H; Lee L; Gao H; Sharif S; Silva RF; Heidari M
    Avian Dis; 2011 Sep; 55(3):358-67. PubMed ID: 22017031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of a recombinant Marek's disease virus in vivo through expression of the Marek's EcoRI-Q (Meq)-encoded oncoprotein: characterization of an rMd5-based mutant expressing the Meq of strain RB-1B.
    Kumar P; Dong H; Lenihan D; Gaddamanugu S; Katneni U; Shaikh S; Tavlarides-Hontz P; Reddy SM; Peters W; Parcells MS
    Avian Dis; 2012 Jun; 56(2):328-40. PubMed ID: 22856190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37.
    Burgess SC; Davison TF
    J Virol; 2002 Jul; 76(14):7276-92. PubMed ID: 12072527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marek's disease virus-induced immunosuppression: array analysis of chicken immune response gene expression profiling.
    Heidari M; Sarson AJ; Huebner M; Sharif S; Kireev D; Zhou H
    Viral Immunol; 2010 Jun; 23(3):309-19. PubMed ID: 20565294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different signaling pathways expressed by chicken naive CD4(+) T cells, CD4(+) lymphocytes activated with staphylococcal enterotoxin B, and those malignantly transformed by Marek's disease virus.
    Buza JJ; Burgess SC
    J Proteome Res; 2008 Jun; 7(6):2380-7. PubMed ID: 18412384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression analysis of host spleen responses to Marek's disease virus infection at late tumor transformation phase.
    Lian L; Qu LJ; Sun HY; Chen YM; Lamont SJ; Liu CJ; Yang N
    Poult Sci; 2012 Sep; 91(9):2130-8. PubMed ID: 22912446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel criteria for the diagnosis of Marek's disease virus-induced lymphomas.
    Gimeno IM; Witter RL; Fadly AM; Silva RF
    Avian Pathol; 2005 Aug; 34(4):332-40. PubMed ID: 16147570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma.
    Uchihara JN; Matsuda T; Okudaira T; Ishikawa C; Masuda M; Horie R; Watanabe T; Ohta T; Takasu N; Mori N
    Int J Cancer; 2006 Mar; 118(5):1098-107. PubMed ID: 16152613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The restricted expression pattern of the Hodgkin's lymphoma-associated cytokine receptor CD30 is regulated by a minimal promoter.
    Dürkop H; Oberbarnscheidt M; Latza U; Bulfone-Paus S; Hirsch B; Pohl T; Krause H; Hummel M; Stein H
    J Pathol; 2000 Oct; 192(2):182-93. PubMed ID: 11004694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neoplastically transformed (CD30hi) Marek's disease lymphoma cell phenotype most closely resembles T-regulatory cells.
    Shack LA; Buza JJ; Burgess SC
    Cancer Immunol Immunother; 2008 Aug; 57(8):1253-62. PubMed ID: 18256827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of a UL5 helicase-primase subunit point mutation eliminates bursal-thymic atrophy of Marek's disease virus ∆Meq recombinant virus but reduces vaccinal protection.
    Hildebrandt E; Dunn JR; Cheng HH
    Avian Pathol; 2015; 44(4):254-8. PubMed ID: 25968878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC expression on spleen lymphocyte subsets in genetically resistant and susceptible chickens infected with Marek's disease virus.
    Dalgaard T; Boving MK; Handberg K; Jensen KH; Norup LR; Juul-Madsen HR
    Viral Immunol; 2009 Oct; 22(5):321-7. PubMed ID: 19811089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
    Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
    Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine gene expression in splenic CD4+ and CD8+ T cell subsets of genetically resistant and susceptible chickens infected with Marek's disease virus.
    Parvizi P; Read LR; Abdul-Careem MF; Sarson AJ; Lusty C; Lambourne M; Thanthrige-Don N; Burgess SC; Sharif S
    Vet Immunol Immunopathol; 2009 Dec; 132(2-4):209-17. PubMed ID: 19615758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus.
    Brown AC; Baigent SJ; Smith LP; Chattoo JP; Petherbridge LJ; Hawes P; Allday MJ; Nair V
    Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1687-92. PubMed ID: 16446447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.